A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia
Latest Information Update: 10 Dec 2024
Price :
$35 *
At a glance
- Drugs Aticaprant (Primary) ; Serotonin uptake inhibitors
- Indications Anhedonia; Major depressive disorder
- Focus Registrational; Therapeutic Use
- Acronyms VENTURA-5
- Sponsors Janssen Research & Development
- 06 Dec 2024 Planned End Date changed from 13 May 2027 to 30 May 2027.
- 15 Oct 2024 New trial record